Cargando…
Augmentation of Transgene-Encoded Protein After Neonatal Injection of Adeno-Associated Virus Improves Hepatic Copy Number Without Immune Responses
BACKGROUND: Achieving persistent expression is a prerequisite for genetic therapies for inherited metabolic enzymopathies. Such disorders potentially could be treated with gene therapy shortly after birth to prevent pathology. However, rapid cell turnover leads to hepatic episomal vector loss, which...
Autores principales: | Tai, Denise S., Hu, Chuhong, Kim, Elizabeth H., Lipshutz, Gerald S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540625/ https://www.ncbi.nlm.nih.gov/pubmed/26042522 http://dx.doi.org/10.1038/pr.2015.109 |
Ejemplares similares
-
AAV-based Neonatal Gene Therapy for Hemophilia A: Long-Term Correction and Avoidance of Immune Responses in Mice
por: Hu, Chuhong, et al.
Publicado: (2012) -
Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes
por: McClements, Michelle E., et al.
Publicado: (2017) -
Transgene Expression Is Associated with Copy Number and Cytomegalovirus Promoter Methylation in Transgenic Pigs
por: Kong, Qingran, et al.
Publicado: (2009) -
Minimal Ureagenesis is Necessary for Survival in the Murine Model of Hyperargininemia Treated by AAV-based Gene Therapy
por: Hu, Chuhong, et al.
Publicado: (2014) -
Carbapenemase-Encoding Gene Copy Number Estimator (CCNE): a Tool for Carbapenemase Gene Copy Number Estimation
por: Jiang, Jianping, et al.
Publicado: (2022)